blog test

William Spencer, Co-founder and CEO of Planet Labs (PL), recently added 100,000 shares. The buy increased his holdings by 8 percent, and came to a total cost of $269,840. This is the first insider buy since April, when a division president bought 274,000 shares. A number of company insiders were massive buyers at the end of 2022. Otherwise, the company’s CFO has been a steady seller of shares each month. In total, company insiders own 2.9 percent of shares. The satellite imaging ...
Read More

Retail chain TJX Companies (TJX) is up nearly 50 percent over the past year, although the stock has come down in the past few weeks. One trader sees a strong rebound in the coming weeks. That’s based on the October $96 calls. With 24 days left until expiration, 20,393 contracts traded compared to a prior open interest of 235, for an 87-fold rise in volume on the trade. The buyer of the calls paid $0.12 to make the bullish bet. Shares recently ...
Read More

No matter how you slice it, companies need to make a profit. That means they need to make money even after all the costs of business. So when those costs rise, so do the prices consumers pay. It can also mean changing returns for investors. For instance, investors in a franchise need to have deep pockets to invest. Most franchise companies require an up-front financial commitment. Increasing those fees is a sign of higher profitability for the management company. After 30 years ...
Read More

Dustin Moskovits, President and CEO at Asana (ASAN), recently bought 1,015,000 shares. The buy increased his stake by 2 percent, and came to a total cost of $18,310,600. This is his second buy of the month, following a 554,847 share pickup on September 8. And this is his 19th buy so far this year. A few company insiders have been sellers of shares this year, with some of those sales coming from the exercise of stock options. Overall, Asana insiders own Read More

Big data firm Palantir Technologies (PLTR) has doubled over the past year, but shares are well off their highs and have slid in recent weeks. One trader sees further weakness ahead. That’s based on the October $12.50 puts. With 25 days until expiration, 9,233 contracts traded compared to a prior open interest of 148, for a 62-fold rise in volume on the trade. The buyer of the puts paid $0.29 to make the bearish bet. Shares recently traded for about $14.00. So ...
Read More

When it comes to shopping at a store, consumers love a deal. Yet when those same consumers are shown a declining stock price, their first instinct is to avoid or sell, not buy. Investors who can look past that trend and look to buy when a stock is on sale can get a good deal. And a sale typically won’t last long on a great, industry-leading company. Taking advantage of those deals can lead to great investment returns over time. One deal ...
Read More

Harry You, a director at Broadcom (AVGO), recently added 1,000 shares. The buy increased his stake by 40 percent, and came to a total cost just under $859,000. The buy comes a week after another director, Check Low, bought 11,000 shares, increasing his stake by 22 percent, and paying just under $9.6 million. These mark the first two insider buys since March 2022, otherwise, company insiders, mostly directors, have been sellers of shares. Overall, Broadcom insiders own 2.3 percent of shares. The ...
Read More

Medical device manufacturer Edwards Lifesciences (EW) is down 14 percent over the past year, with shares taking a beating in recent sessions. One trader sees a potential rebound ahead in the coming weeks. That’s based on the October $82.50 calls. With 28 days until expiration, 5,738 contracts traded compared to a prior open interest of 209, for a 27-fold rise in volume on the trade. The buyer of the calls paid $0.55 to make the bullish bet. Edwards shares recently traded ...
Read More